Centessa Pharmaceuticals (CNTA) EPS (Basic) (2021 - 2026)
Centessa Pharmaceuticals (CNTA) reported EPS (Basic) of -$0.52 for Q1 2026, down 160.0% year-over-year from $0.87 in Q1 2025, and down 8.33% on a QoQ basis from -$0.48 in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 6 years of EPS (Basic) data on file, last reported at -$0.52 in Q1 2026.
- Quarterly EPS (Basic) fell 160.0% year-over-year to -$0.52 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.79 (up 4.79% YoY) and the FY2025 annual result came in at -$1.46, up 29.13% from the prior year.
- EPS (Basic) declined to -$0.52 in Q1 2026 per CNTA's latest filing, from -$0.48 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.2 in Q1 2025 and bottomed at -$0.91 in Q4 2024.
- The 5-year median for EPS (Basic) is -$0.41 (2025), against an average of -$0.47.
- The widest annual swing landed in 2022, when EPS (Basic) surged 87.93%; it then plunged 160.0% in 2026.
- Tracing CNTA's EPS (Basic) over 5 years: stood at -$0.45 in 2022, then rose by 17.78% to -$0.37 in 2023, then sank by 145.95% to -$0.91 in 2024, then surged by 47.25% to -$0.48 in 2025, then fell by 8.33% to -$0.52 in 2026.
- Per Business Quant, the three latest CNTA EPS (Basic) figures stand at -$0.52 (Q1 2026), -$0.48 (Q4 2025), and -$0.41 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | -0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.52 |
| Dec 31, 2025 | -0.48 |
| Sep 30, 2025 | -0.41 |
| Jun 30, 2025 | -0.38 |
| Mar 31, 2025 | -0.20 |
| Dec 31, 2024 | -0.91 |
| Sep 30, 2024 | -0.37 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -0.38 |
| Dec 31, 2023 | -0.37 |
| Sep 30, 2023 | -0.40 |
| Jun 30, 2023 | -0.26 |
| Mar 31, 2023 | -0.53 |
| Dec 31, 2022 | -0.45 |
| Sep 30, 2022 | -0.57 |
| Jun 30, 2022 | -0.69 |
| Mar 31, 2022 | -0.60 |
| Dec 31, 2021 | -0.47 |
| Sep 30, 2021 | -0.45 |
| Jun 30, 2021 | -0.65 |
| Mar 31, 2021 | -4.97 |